Sign Up Today and Learn More About Blaze Bioscience Stock

Invest in or calculate the value of your shares in Blaze Bioscience or other pre-IPO companies through EquityZen's platform.

Get Started

Blaze Bioscience Stock

Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.

About Blaze Bioscience Stock

Founded

2010

Headquarters

Seattle, WA, US

Total Funding

35.2M

Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. The company was founded in 2010 to develop and commercialize the Tumor Paint technology. Tumor Paint provides real-time, highresolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.

Blaze Bioscience Press Mentions

Stay in the know about the latest news on Blaze Bioscience

Blaze Bioscience Management

Leadership team at Blaze Bioscience

Founder

James Olson

President & CEO

Heather Franklin

Locked Features

Join now and verify your accreditation status to gain access to:

  • Blaze Bioscience current valuation
  • Blaze Bioscience stock price
  • Available deals in Blaze Bioscience and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Blaze Bioscience stock?

Accredited investors can buy pre-IPO stock in companies like Blaze Bioscience through EquityZen funds. These investments are made available by existing Blaze Bioscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Blaze Bioscience stock?

Shareholders can sell their Blaze Bioscience stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."